Abstract
Background
Capsular contracture is the most common complication of breast augmentation and reconstruction. It occurs in up to 45% of patients and is theorized to occur secondary to an immune reaction. It can lead to pain, dissatisfaction with aesthetic outcomes, and reoperation. The gold standard for management is capsulectomy. Prior similar studies are limited by narrow inclusion criteria, single-surgeon analysis, small sample size, or univariate analysis. The goal of the following study is to prospectively identify possible risk factors for capsular contracture using a national database.
Methods
A retrospective review was conducted utilizing the National Surgical Quality Improvement Program (NSQIP) Database of prospectively collected data of patients undergoing periprosthetic and/or total capsulectomy for capsular contracture from 2013 to 2016. Odds ratios (OR) with 95% confidence intervals (CI) were calculated for variables using a multivariable binary logistic regression model.
Results
A total of 6547 patients underwent reconstructive or augmentation mammaplasty with a prosthetic implant, out of which 2543 (39%) underwent capsulectomy. Capsular contracture was more likely in older (OR: 1.10, 95% CI: 1.09–1.10, p<.001), overweight (OR: 1.12, 95% CI: 1.10–1.13, p<.001), and cancer patients (OR: 7.71, 95% CI: 2.22–28.8, p=0.001). Wound infection was associated with capsulectomy (OR: 6.69, 95% CI: 1.74–25.8, p<.001). Conclusion: These identified risk factors should be comprehensively addressed with patients during the informed consent process before breast augmentation or reconstruction with implants.
Level of Evidence III
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
Similar content being viewed by others
References
American Society of Plastic Surgeons (2020) Plastic surgery statistics report. ASPS national clearinghouse of plastic surgery procedural statistics.
Malahias M, Jordan DJ, Hughes LC, Hindocha S, Juma A (2016) A literature review and summary of capsular contracture: an ongoing challenge to breast surgeons and their patients. Int J Surg Open 3:1–7
Headon H, Kasem A, Mokbel K (2015) Capsular contracture after breast augmentation: an update for clinical practice. Arch Plast Surg 42(5):532–543
Bachour Y, Bargon CA, de Blok CJM, Ket JCF, Ritt MJPF, Niessen FB (2018) Risk factors for developing capsular contracture in women after breast implant surgery: a systematic review of the literature. J Plast Reconstr Aesthet Surg 71(9):e29–e48
Calobrace MB, Stevens WG, Capizzi PJ, Cohen R, Godinez T, Beckstrand M (2018) Risk factor analysis for capsular contracture: a 10-year sientra study using round, smooth, and textured implants for breast augmentation. Plast Reconstr Surg 141:20S-28S
McGuire P, Reisman NR, Murphy DK (2017) Risk factor analysis for capsular contracture, malposition, and late seroma in subjects receiving natrelle 410 formstable silicone breast implants. Plast Reconstr Surg 139(1):1–9
Egeberg A, Sørensen JA (2016) The impact of breast implant location on the risk of capsular contraction. Ann Plast Surg 77(2):255–259
Ajdic D, Zoghbi Y, Gerth D, Panthaki ZJ, Thaller S (2016) The relationship of bacterial biofilms and capsular contracture in breast implants. Aesthet Surg J 36(3):297–309
Galdiero M, Larocca F, Iovene MR et al (2018) Microbial evaluation in capsular 13 contracture of breast implants. Plast Reconstr Surg 141(1):23–30
Salzberg CA, Ashikari AY, Berry C, Hunsicker LM (2016) Acellular dermal matrixassisted direct-to-implant breast reconstruction and capsular contracture: a 13-year experience. Plast Reconstr Surg 138(2):329–337
Jacobson JM, Gatti ME, Schaffner AD, Hill LM, Spear SL (2012) Effect of incision choice on outcomes in primary breast augmentation. Aesthet Surg J 32(4):456–462
Marques M, Brown SA, Oliveira I et al (2010) Long-term follow-up of breast capsule contracture rates in cosmetic and reconstructive cases. Plast Reconstr Surg 126(3):769778
Namnoum JD, Largent J, Kaplan HM, Oefelein MG, Brown MH (2013) Primary breast augmentation clinical trial outcomes stratified by surgical incision, anatomical placement and implant device type. J Plast Reconstr Aesthet Surg 66(9):1165–1172
Largent JA, Reisman NR, Kaplan HM, Oefelein MG, Jewell ML (2013) Clinical trial outcomes of high-and extra high-profile breast implants. Aesthet Surg J 33(4):529–539
Dancey A, Nassimizadeh A, Levick P (2012) Capsular contracture-What are the risk factors? A 14 year series of 1400 consecutive augmentations. J Plast Reconstr Aesthet Surg 65(2):213–218
Serritzlev MS, Lorentzen AK, Matthiessen LW, Hölmich LR (2020) Capsular contracture in patients with prior breast augmentation undergoing breast conserving therapy and irradiation. J Plast Surg Hand Surg 54(4):225–232
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Thaller receives royalties from Thieme and Springer Publishers.
Human or Animal Participant
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed Consent
For this type of study informed consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ali, A., Picado, O., Mathew, P.J. et al. Risk Factors for Capsular Contracture in Alloplastic Reconstructive and Augmentation Mammaplasty: Analysis of the National Surgical Quality Improvement Program (NSQIP) Database. Aesth Plast Surg 47, 1678–1682 (2023). https://doi.org/10.1007/s00266-022-02972-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-022-02972-x